17 Oct Injectable drug to ease advanced Parkinson’s disease symptoms approved by FDA
The drug is a 24-hour infusion injected below the skin that treats motor fluctuations in patients with advanced Parkinsons....
The drug is a 24-hour infusion injected below the skin that treats motor fluctuations in patients with advanced Parkinsons....
Artificial Intelligence (AI) is on the cusp of quickly becoming a large component of the healthcare industry (broadly defined), with the emergence of generative AI and sophisticated predictive models making significant inroads across various domains....
Two experts on regulatory and compliance trends weigh in on the FDA's recently issued guidance on decentralized clinical trials....
The more-than-475,000-square-foot, seven-story Eastpark Medical Center, will offer more than 40 types of specialty care and support hundreds of clinical trials....
A review of the FDA's regulation of artificial intelligence (AI) and the potential uses of AI in medical product development, clinical research, and clinical care....
Strong performance in the categories of teaching and research environment helped the University of Wisconsin–Madison rise to 56th in the 2025 Times Higher Education World University Rankings....
Recent findings from an NIH-supported clinical trial, show that daily treatment with pomalidomide, a cancer drug, led to a significant reduction in nosebleed severity for people with a rare blood vessel disorder....
UW Health patients, who choose to participate, will have seamless access to clinical trials at the new Eastpark Medical Center....
Sarah Kotila, a nurse who’s also the clinical trials navigator manager at the UW Carbone Cancer Center, recently joined Wisconsin Public Radio to discuss some misconceptions about cancer and clinical trials....
Wisconsin scientists are among those conducting dozens of clinical trials worldwide on the use of psilocybin to treat depression. They say the evidence shows that, in combination with therapy, it shows great promise. ...